Reply to “SIV and HIV prophylaxis”

Article metrics

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Lehner, T. et al. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Med. 2, 767–776 (1996).

  2. 2

    Müllbacher, A. & Flynn, K. Aspects of cytotoxic T cell memory. Immunol. Rev. 150, 113–128 (1996).

  3. 3

    Tough, D.F., Borrow, P. & Sprent, J. Induction of bystander T cell proliferation by viruses and type 1 interferon in vivo. Science 272, 1947–1950 (1996).

  4. 4

    Beverly, P.C.L. Human T cell memory. Curr. Top. Microbiol. Immunol. 159, 111 (1990).

  5. 5

    Levy, J.A., Mackewicz, C.E. & Barker, E. Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol. Today 17, 217 (1996).

  6. 6

    Baier, M., Werner, A., Bannert, N., Metzner, K. & Kurth, R. HIV suppression by interleukin-16. Nature 378, 563 (1995).

  7. 7

    Bleul, C.C. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829 (1996).

  8. 8

    Oberlin, E. et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T cell line adapted HIV-1. Nature 382, 833 (1996).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article